David S. Riddle
University of Washington
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David S. Riddle.
Nature Structural & Molecular Biology | 1999
David S. Riddle; Viara P. Grantcharova; Jed V. Santiago; Eric Alm; Ingo Ruczinski; David Baker
We use a combination of experiments, computer simulations and simple model calculations to characterize, first, the folding transition state ensemble of the src SH3 domain, and second, the features of the protein that determine its folding mechanism. Kinetic analysis of mutations at 52 of the 57 residues in the src SH3 domain revealed that the transition state ensemble is even more polarized than suspected earlier: no single alanine substitution in the N-terminal 15 residues or the C-terminal 9 residues has more than a two-fold effect on the folding rate, while such substitutions at 15 sites in the central three-stranded β-sheet cause significant decreases in the folding rate. Molecular dynamics (MD) unfolding simulations and ab initio folding simulations on the src SH3 domain exhibit a hierarchy of folding similar to that observed in the experiments. The similarity in folding mechanism of different SH3 domains and the similar hierarchy of structure formation observed in the experiments and the simulations can be largely accounted for by a simple native state topology-based model of protein folding energy landscapes.
Nature Structural & Molecular Biology | 1998
Viara P. Grantcharova; David S. Riddle; Jed V. Santiago; David Baker
Experimental and theoretical studies on the folding of small proteins such as the chymotrypsin inhibitor 2 (CI-2) and the P22 Arc repressor suggest that the folding transition state is an expanded version of the native state with most interactions partially formed. Here we report that this picture does not hold generally: a hydrogen bond network involving two β-turns and an adjacent hydrophobic cluster appear to be formed in the folding transition state of the src SH3 domain, while the remainder of the polypeptide chain is largely unstructured. Comparison with data on other small proteins suggests that this structural polarization is a consequence of the topology of the SH3 domain fold. The non-uniform distribution of structure in the folding transition state provides a challenging test for computational models of the folding process.
Current Opinion in Structural Biology | 1998
Kevin W. Plaxco; David S. Riddle; Viara P. Grantcharova; David Baker
Recent research has suggested that stable, native proteins may be encoded by simple sequences of fewer than the full set of 20 proteogenic amino acids. Studies of the ability of simple amino acid sequences to encode stable, topologically complex, native conformations and to fold to these conformations in a biologically relevant time frame have provided insights into the sequence determinants of protein structure and folding kinetics. They may also have important implications for protein design and for theories of the origins of protein synthesis itself.
Molecular Therapy | 2005
Susanne Lang; David S. Riddle; Laura Sanz; Heung Chong; Jill Thompson; Richard Vile
We hypothesized that inducing display of the IgFc molecule on the tumor cell surface by gene transfer would promote tumor cell killing by the same mechanisms as antibody based approaches, but would alleviate some of the problems inherent in the use of antibodies for cancer therapy. We expressed the cDNA of the Fc portion of the murine IgG2a heavy chain on the surface of tumor cells thereby mimicking a natural antibody tagging event. In vitro, Fc receptor positive natural killer cells specifically recognized and lysed B16 melanoma cells expressing surface IgFc. Macrophages bound to B16-Fc, cells significantly more than to parental B16 and surface IgFc expression promoted formation of the terminal complement pore complex. Expression of the IgFc dramatically delayed the ability of B16 cells to form tumors in vivo, dependent on macrophages and NK cells.
Nature Structural & Molecular Biology | 1997
David S. Riddle; Jed V. Santiago; Susan T. Bray-Hall; Nikunj Doshi; Viara P. Grantcharova; Qian Yi; David Baker
Proceedings of the National Academy of Sciences of the United States of America | 2000
Viara P. Grantcharova; David S. Riddle; David Baker
Cancer Research | 2002
Andrew Bateman; Kevin J. Harrington; Tim Kottke; Atique U. Ahmed; Alan Melcher; Michael J. Gough; Emmanouela Linardakis; David S. Riddle; Allan B. Dietz; Christine M. Lohse; Scott E. Strome; Tim Peterson; Robert D. Simari; Richard G. Vile
Cancer Research | 2001
Michael J. Gough; Alan Melcher; Atique U. Ahmed; Marka Crittenden; David S. Riddle; Emmanouela Linardakis; Anja Ruchatz; Lisa Emiliusen; Richard G. Vile
Journal of Molecular Biology | 2000
Kevin W. Plaxco; Stefan M. Larson; Ingo Ruczinski; David S. Riddle; Edward C. Thayer; Brian Buchwitz; Alan R. Davidson; David Baker
Protein Science | 1995
Hongdi Gu; Qian Yi; S. T. Bray; David S. Riddle; A. K. Shiau; David Baker